Table 1.
Baseline Characteristics of Patients With Acute COVID‐19 (N=33)
| Patients | |
|---|---|
| Demographics and past medical history | |
| Age, y | 51 [34–56] |
| Current/exsmokers | 6 (18.2) |
| Diabetes | 10 (31) |
| Hypertension | 11 (33) |
| HIV | 4 (13) |
| Clinical assessments | |
| Symptom duration, days | 4 [2–7] |
| Systolic BP, mm Hg | 127 [120–136] |
| Diastolic BP, mm Hg | 78 [70–85] |
| Heart rate, bpm | 88 [80–92] |
| COVID‐19 treatments | |
| Oxygen requirement | 19 (58) |
| Remdesevir | 4 (13) |
| Dexamethasone | 15 (47) |
| SARS‐CoV‐2 PCR (cycle threshold) | 25 [20–29] |
| Laboratory measurements | |
| Creatinine, μmol/L | 97 [60–108] |
| White cell count, ×109/L | 6 [5–9] |
| D‐dimer, mcg/mL | 0.66 [0.37–1.09] |
| C‐reactive protein, mg/L | 55 [25–101] |
| Procalcitonin, ng/mL | 0.07 [0.04–0.12] |
| NT‐proBNP, pg/mL | 35 [28–151] |
| Troponin, ng/L | 3.88 [2.76–7.18] |
Data are provided as number (percentage) or median [interquartile range]. BP indicates blood pressure; NT‐proBNP, N‐terminal pro–brain natriuretic peptide; and PCR, polymerase chain reaction.